VX-770 Expanded Access Program
NCT01381289
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Conditions
Cystic Fibrosis
Interventions
DRUG:
VX-770
Sponsor
Vertex Pharmaceuticals Incorporated